Semaglutide and Alcohol - Do They Mix?
US$ 20.97
pharma news today obesity drugs glp-1 october 2025 health Outlook for obesity in 2025: more Anti-Obesity Drugs Market Report 2025
Description
In a recent study, researchers found that GLP-1RA medications such as Ozempic and Wegovy are associated with a higher risk of post-endoscopy aspiration pneumonia.
Insurers raised cost-sharing sharply for GLP-1s in recent years and also increased use of prior authorization.
RESET YOUR WEIGHT
Wegovy, the GLP-1 medication to treat obesity from Lilly competitor Novo Nordisk, will still be covered under plans managed by CVS Caremark.
Learn how they work, who theyre for, and why theyre making headlines.
These GLP-1 botanical patches also feature L-Glutamine
